Skip to search formSkip to main contentSkip to account menu

Provenge

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2015
Review
2015
Cancer immunotherapy has recently emerged as an important treatment modality. FDA approval of provenge, ipilimumab and… 
Highly Cited
2011
Highly Cited
2011
Therapies for prostate cancer depend on age, rate of the cancer’s growth, the specific benefits and drawbacks of treatment, and… 
2010
2010
  • V. Brower
  • Journal of the National Cancer Institute
  • 2010
  • Corpus ID: 33468632
Adecade in development, Dendreon’s prostate cancer vaccine, sipuleucelT (Provenge), has become the first therapeutic cancer…